Akari Therapeutics

Tick saliva-derived drug shows promise in mid-stage rare skin disease study
Endpoints
Sat, 05/2/20 - 11:24 pm
Akari Therapeutics
ticks
skin diseases
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 04/28/19 - 10:00 pm
Regeneron
Sanofi
Praluent
FDA
Heron Therapeutics
HTX-011
Nabiva
Orchard Therapeutics
Akari Therapeutics
Aldeyra Therapeutics
BioTime
Audentes Therapeutics
Adaptimmune
GW Pharma
Ionis
Biogen
Ovid Therapeutics
TransMedics
IPOs
Trevi Therapeutics
Akari CEO Abruptly Resigns Following Abuse of Corporate Credit Card
BioSpace
Sat, 05/12/18 - 11:38 am
Akari Therapeutics
Pharma CEOs
David Horn Solomon
Akari CEO resigns amidst dodgy data claims
BioPharma Dive
Thu, 06/1/17 - 11:55 pm
Akari Therapeutics
Pharma CEOs
PNH
clinical trials